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ABSTRACT The objective of this study is to analyze the perinatal results of the prophylac-
tic measures adopted in the prevention of the vertical transmission of HIV. The study was 
carried out using the medical records of 168 women with HIV and their newborns in a 
public maternity unit of Fortaleza, in the state of Ceará, from 2005 to 2009. The data was 
obtained between the months of March and September 2010 and was analyzed using 
the program SPSS 10.0. The women diagnosed before pregnancy received timely care 
that permitted them an effective antiretroviral therapy and a greater number of check-ups 
(p<0,05). Antiretroviral therapy was administered to 97.6% of the pregnant women, and 
triple therapy in 88.7%. AZT was administered intrapartum in 95.2% of the women and 
oral AZT in syrup to 100% of the newborns. Birth by cesarean section was predominant 
(92.8%) and was associated to the intrapartum use of AZT when compared to vaginal 
birth (p<0.001). Cesarean section favored intrapartum administration of AZT.
KEY WORDS Prenatal care; HIV Infections / prevention & control; AIDS Serodiagnosis; 
Delivery, Obstetric; Brazil. 
RESUMEN El objetivo de este estudio es analizar los resultados perinatales de las medidas 
profilácticas adoptadas en la prevención de la transmisión vertical del VIH. Se realizó 
una investigación de las historias clínicas de 168 mujeres con VIH y sus recién nacidos 
en una maternidad pública de Fortaleza, estado de Ceará, entre 2005 y 2009. Los datos 
se obtuvieron entre los meses de marzo y septiembre de 2010 y fueron analizados con 
el programa SPSS 10.0. Las embarazadas que conocían el diagnóstico en forma previa al 
embarazo tuvieron una rápida atención que permitió una terapia antirretroviral eficaz y 
un mayor número de controles (p<0,05). Se administró terapia antirretroviral al 97,6% 
de las embarazadas, triple esquema al 88,7%; AZT intraparto al 95,2% y AZT oral en 
jarabe al 100% de los recién nacidos. Predominó la cesárea (92,8%) asociada al AZT 
intraparto al ser cotejada con el parto vaginal (p<0,001). La cesárea proporcionó mayor 
administración de AZT intraparto. 
PALABRAS CLAVES Atención Prenatal; Infecciones por VIH / prevención & control; 
Serodiagnóstico del SIDA; Parto Obstétrico; Brasil.
364 DAMASCENO KSA, ALVES DOS PRAZERES JC, ARAÚJO MAL, VALDANHA NETTO A. 
SA
LU
D
 C
O
LE
C
TI
V
A
, B
ue
no
s 
A
ire
s,
 9
(3
):3
63
-3
71
, S
ep
te
m
be
r -
 D
ec
em
be
r, 
20
13
Universidad Nacional de Lanús | Salud Colectiva | ISSN 1669-2381 | ISSN 1851-8265
INTRODUCTION
Vertical transmission is the main route of in-
fection by Human Immunodeficiency Virus (HIV) 
among children under 13 years of age in Brazil 
and accounts for 92.9% of the cases registered 
in 2008 (1). With an HIV prevalence of 0.40% 
among pregnant women, it is estimated that 
12,456 newborns would be exposed to infection 
on an annual basis (2).
Vertical transmission may occur during ges-
tation, childbirth or breastfeeding (3), with child-
birth considered the moment of greatest risk of 
transmission due to the newborn’s contact with the 
blood and vaginal secretions of the mother (4,5).
The use of zidovudine (AZT) began to be rec-
ommended as a method of prevention for vertical 
HIV transmission after the first clinical trial (ACTG 
076) was published (6). The study showed a 
drastic reduction of this form of transmission when 
AZT was administered from week 14 of gestation 
onward, during childbirth and to the newborn (7).
It is estimated that without intervention the 
transmission rate would be close to 30% (8,9). 
However, some studies have shown that trans-
mission could be reduced to less than 2% (10,11) 
with the implementation of the prophylactic 
measures recommended and the performance 
of elective cesarean section if the viral load after 
week 34 of gestation were superior to 1000 
copies/ml (or unknown).
According to a study conducted by Newell et 
al. (12) in 2004, the mortality rate among children 
under one year of age who were infected with HIV 
through vertical transmission was approximately 
nine times greater than that of uninfected children. 
Another study carried out in Nigeria compared a 
group of HIV-positive pregnant women who were 
treated with antiretrovirals during pregnancy with 
other groups of untreated women and it was found 
that the rate for vertical transmission of the first 
group was 4.8% while the rate of the other groups 
reached 19.5%, thus confirming the effectiveness 
of prophylactic measures (13).
As for Brazil, the gradual implementation of 
prophylactic measures caused a reduction in the 
incidence of vertical HIV transmission, which 
dropped from 904 to 66 cases between the years 
2000 and 2010 (1). This reduction demonstrates 
that this form of infection can be prevented 
through the effective implementation of proper 
prophylactic measures.
Early HIV diagnosis and the adoption of pro-
phylactic measures during pregnancy, childbirth, 
postpartum and breastfeeding are essential in the 
process of prevention of vertical transmission. 
Moreover, these measures can also help carry 
out the follow-up of HIV-exposed infants, which 
allows those children with confirmed diagnosis to 
have early access to the treatment.
Given the aforementioned context and the 
importance of the subject, this study aims at de-
scribing the prenatal care, labor and mode of 
delivery provided to pregnant women with HIV/
AIDS and their newborns in a public maternity 
unit in Fortaleza, Ceará, Brazil, between the years 
2005 and 2009.
METHODOLOGY
A retrospective study was conducted among 
all pregnant women infected with HIV/AIDS who 
received prenatal care and gave birth in a ter-
tiary care maternity unit in the city of Fortaleza, 
Ceará between the years 2005 and 2009. This ma-
ternity unit carries out follow-up with HIV-positive 
pregnant women referred from the Unidades 
Básicas de Saúde [basic health units] and other 
health care facilities. Pregnant women are ad-
mitted to this maternity unit with the first positive 
HIV test. Later they undergo a second test for confir-
mation of diagnosis as well as a Papanicolaou test.
Data collection was conducted from March 
to September in 2010. The information on the pre-
natal care of the mothers was extracted from both 
inpatient and outpatient medical records while 
the information on childbirths and newborns was 
obtained from inpatient medical records. The out-
patient medical records were designed for the spe-
cific use of the health care services for pregnant 
women with HIV/AIDS to be filled in during 
routine check-ups.
The study excluded data from women who 
did not give birth in the maternity unit where the 
study was conducted, women whose medical 
records were not found and women with uncon-
firmed HIV diagnosis. In the case of women who 
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had delivered more than one child, only the data 
on the last pregnancy was included.
The variables analyzed in the mothers were: 
age, level of educational attainment, whether they 
had a stable partner, knowledge of serological 
status before pregnancy, gestational age at the 
start of prenatal care estimated according to the 
date of last menstrual period or ultrasound per-
formed at the HIV/AIDS health care unit, number 
of medical check-ups, Papanicolaou test results re-
ported according to the Bethesda system (14), use 
of antiretroviral therapy, gestational age at the be-
ginning of antiretroviral therapy, type of treatment 
administered, mode of delivery, whether pre-
mature rupture of membranes occurred and in-
terval between membrane rupture and delivery, 
and whether AZT was administered intrapartum 
as a prophylactic measure. The variables analyzed 
among newborns included: birth weight, gesta-
tional age determined by the Capurro method, 
birth weight for gestational age based on the 
World Health Organization (WHO) growth charts 
(15), and administration of oral AZT in syrup.
Data was registered in the statistical software 
SPSS 18.0. Initially, a univariate analysis was con-
ducted, calculating proportions for the categorical 
variables and measures of central tendency for the 
numerical variables. Pearson’s chi-squared test 
was adopted to analyze differences between the 
categorical variables, with a significance level set 
at 5%. A bivariate analysis was then carried out 
using the statistical software package STATA 11.0. 
The odds ratio (OR) was used as the measure of 
effect with a 95% confidence interval.
This article is part of a more comprehensive 
study titled “Perfil Epidemiológico de gestantes 
HIV positivas atendidas no ambulatório de pre-
venção da transmissão vertical da Maternidade 
Escola Assis Chateaubriand da Universidade 
Federal do Ceará” approved by the Research 
Ethics Committee of the Universidade Federal do 
Ceará (UFC) under protocol number 13/07.
FINDINGS
During the period under review, the health 
care service for HIV prevention performed pre-
natal check-ups for 187 HIV-positive women, of 
which the medical records of 168 pregnant women 
and their newborns were included in the study. 
Nineteen medical records were excluded: in eight 
of them the serum sample analysis did not confirm 
HIV infection, in four of them it was impossible to 
Table 1. Sociodemographic and prenatal care 
data of pregnant women with HIV/AIDS who 
received medical care in a public maternity unit 
of Fortaleza, Ceará, Brazil, 2005-2009. (n=168)
Variables Pregnant women
n %
Age
≤ 18 10 6.0
19-29 104 61.9
> 29 54 32.1
Level of educational attainment
Primary education complete/
incomplete 94 56.0
Secondary education complete/
incomplete 58 34.5
Higher education complete/
incomplete 4 2.4
Unknown 12 7.1
Stable partnership
Yes 156 92.9
No 3 1.8
Unknown 9 5.3
Start of prenatal care 
(trimester)
First 39 23.2
Second 86 51.2
Third 43 25.6
Number of prenatal check-ups
< 6 89 53.0
≥ 6 79 47.0
Use of ARVT
Yes 164 97.6
No 3 1.8
Unknown 1 0.6
Type of ARVT
Monotherapy 3 1.8
Triple therapy 149 88.7
Therapy without AZT use 4 2.4
Unknown 12 7.1
Beginning of ARVT (trimester)
First 37 22.0
Second 66 39.3
Third 42 25.0
Unknown 23 13.7
Source: Own elaboration based on data from inpatient and outpatient 
medical records provided by the health care service for the prevention of 
vertical transmission of the Maternidade Escola Assis Chateaubriand of 
the Universidade Federal do Ceará.
ARVT = Antiretroviral therapy.
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find the records, and in five of them the baby was 
not delivered at the studied maternity unit.
The mothers’ ages ranged from 15 to 43 years, 
with an average of 26 ± 6 years (mean ± SD); 104 
women (61.9%) were between 19 and 29 years 
old, and 10 women (6.0%) were 18 years old or 
younger; 58 women (34.5%) were studying or had 
finished secondary school and only 4 women 
(2.4%) had attained higher education; 156 women 
(92.9%) had a stable partner at the time of the pre-
natal check-up (Table 1).
 The average gestational age at the start of 
prenatal care was 22 weeks; 89 pregnant women 
(53.0%) had less than six check-ups and the av-
erage number of check-ups in the referral ma-
ternity unit was 5.6. Seventy-six percent began 
their prenatal care between the second and the 
third trimester of pregnancy (51.2% in the second 
trimester and 25.6% in the third), 129 women in 
all. The HIV status before pregnancy was known 
by 89 women (53.0%).
Antiretroviral therapy was administered 
during pregnancy to 164 pregnant women 
(97.6%). Triple therapy was administered to 149 
of these women (88.7%), with AZT as part of 
the prescribed therapy in all cases. Therapy was 
started in the third trimester in 42 cases (25.0%). 
Papanicolaou test results were available in 161 
outpatient medical records (95.8%), 22 of which 
presented some type of abnormality (13.1%): 14 
(63.6%) due to low-grade squamous intraepi-
thelial lesion (LSIL), 5 (22.7%) due to high-grade 
squamous intraepithelial lesion (HSIL), and 3 
(13.6%) due to atypical squamous cells of unde-
termined significance (ASC-US).
During childbirth, 160 women (95.2%) were 
injected with AZT. Mode of delivery was cesarean 
section in 156 cases (92.8%), out of which 145 
cases were elective cesareans. Out of the total 
number of deliveries, 14 women had premature 
rupture of membranes; in 12 cases, the interval 
between rupture and delivery was obtained and 
in 8 of them, the interval was four hours or longer. 
Gestational age was more than 37 weeks in 144 
cases (85.7%).
Regarding the newborns, 166 (98.8%) were 
administered oral AZT in syrup during the first 
eight hours of life; 150 (89.3%) presented appro-
priate weight for gestational age; and 142 (84.5%) 
weighed 2500 grams or over (Table 2). 
Table 3 displays a bivariate analysis regarding 
the women’s knowledge of HIV diagnosis before 
pregnancy. A statistically significant difference was 
observed between knowledge of diagnosis before 
pregnancy and start of prenatal care (OR=8.16; 
95%CI [2.61; 33.46]; p<0.001), number of check-
ups (OR=4.61; 95%CI [2.28; 9.39]; p<0.001) 
and start of antiretroviral therapy before the third 
trimester of pregnancy (OR=5.70; 95%CI [2.37; 
14.38]; p<0.001).
 
 
Table 2. Data on childbirth and newborns of 
women with HIV/AIDS who received medical 
care in a public maternity unit of Fortaleza, 
Ceará, Brazil. 2005-2009. (n=168) 
Variables Newborns
n %
Mode of delivery
Elective cesarean 145 86.3
Vaginal 12 7.1
Cesarean with membrane rupture 11 6.5
Use of AZT intrapartum 
Yes 160 95.2
No 8 4.8
Premature rupture of 
membranes
Yes 14 8.3
No 154 91.7
Duration of rupture (n=12)
< 4 h 4 33.3
≥ 4 h 8 66.7
Gestational age (Capurro 
method)
32 weeks 3 1.8
32 to 37 weeks 21 12.5
> 37 weeks 144 85.7
Newborn’s birth weight for 
gestational age 
Appropriate for GA 150 89.3
Small for GA 15 8.9
Large for GA 3 1.8
Use of oral AZT in syrup
Yes 166 98.8
No 2 1.2
Newborn’s birth weight
< 2500 g 26 15.5
≥ 2500 g 142 84.5
Source: Own elaboration based on data from inpatient and outpatient 
medical records provided by the health care service for the prevention of 
vertical transmission of the Maternidade Escola Assis Chateaubriand of 
the Universidade Federal do Ceará.
GA = Gestational age.
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Table 4 shows findings from the analysis of 
the relation between mode of delivery of HIV-
positive women and start of prenatal care, use 
of AZT intrapartum and the occurrence of pre-
mature rupture of membranes. A statistically 
significant association was observed between 
the performance of cesarean delivery and the 
use of AZT intrapartum (OR=0.05; CI95% 0.00-
3.51; p<0.001) and for rupture of membranes 
(OR=0.22; CI95% 0.05-0.96; p=0.030).
Table 4. Relation between mode of delivery and start of prenatal care, use of AZT 
intrapartum and premature rupture of membranes in women with HIV/AIDS who 
received medical care in a public maternity unit of Fortaleza-Ceará, Brazil. 2005-2009. 
(n=168)
Variable Mode of delivery OR 95%CI p-value
Cesarean Vaginal
n % n %
Start of prenatal care 
(weeks)
≤ 13 29 18.6 2 16.7
0.87 0.18; 4.21 0.868
> 13 127 81.4 10 83.3
Use of AZT intrapartum
Yes 152 97.4 8 66.7
0.05 0.00; 3.51 <0.001
No 4 2.6 4 33.3
Premature rupture of 
membranes
Yes 11 7.1 3 25.0
0.22 0.05; 0.96 0.030
No 145 92.9 9 75.0
Source: Own elaboration based on data from inpatient and outpatient medical records provided by the health care service for the prevention of 
vertical transmission of the Maternidade Escola Assis Chateaubriand of the Universidade Federal do Ceará.
OR = Odds ratio. I95%CI = 95% Confidence interval.
Table 3. Knowledge of HIV diagnosis before pregnancy and start of prenatal care, 
number of check-ups, start of antiretroviral therapy and mode of delivery in pregnant 
women who received medical care in a public maternity unit of Fortaleza, Ceará, Brazil. 
2005-2009. (n=168)
Variable Knowledge of HIV diagnosis OR 95%CI p-value
Yes No
n % n %
Start of prenatal care (weeks)
≤ 13 27 30.3 4 5.1
8.16 2.61; 33.46 <0.001
> 13 62 69.7 75 94.9
Number of check-ups
< 6 32 36.0 57 72.2
4.61 2.28; 9.39 <0.001
≥ 6 57 64.0 22 27.8
Start of ARVT (trimester)
Before the third 66 74.2 37 46.8
5.70 2.37; 14.38 <0.001
During the third 23 25.8 42 53.2
Mode of delivery
Cesarean 82 92.1 74 93.7
1.26 0.32; 5.27 0.699
Vaginal 7 7.9 5 6.3
Source: Own elaboration based on data from inpatient and outpatient medical records provided by the health care service for the prevention of 
vertical transmission of the Maternidade Escola Assis Chateaubriand of the Universidade Federal do Ceará.
OR = Odds ratio. 95%CI = 95% Confidence interval. ARVT = Antitetroviral therapy.
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Figure 1 shows a comparative analysis be-
tween gestational age and mode of delivery. A 
greater number of premature newborns (<37 
weeks) can be observed among the group of in-
fants born by vaginal delivery or by cesarean 
section with rupture of membranes (p<0.001).
 
DISCUSSION
It can be observed that almost every woman 
received antiretroviral therapy during the preg-
nancy, although in seven cases triple therapy was 
not administered. It would be useful to identify the 
reasons why combined therapy was not used, since 
this form of therapy significantly decreases plasma 
viral load and causes less drug resistance (16,17).
A significant percentage of pregnant women 
(25.6%) began to receive antiretroviral therapy at 
more than 28 weeks of gestation, and among this 
group, 76.1% had received a diagnosis of HIV 
infection during pregnancy, which demonstrates 
the importance of measures that facilitate access 
of pregnant women not only to HIV testing but 
also to treatment. It should be highlighted that, 
notwithstanding the effectiveness of antiretroviral 
drugs when used in the last trimester of pregnancy 
onward (18), it is recommended that antiretroviral 
therapy be started as from week 14 of gestation – 
a recommendation which is hardly ever observed 
by the health care services.
AZT intrapartum was administered to 94% of 
the pregnant women, and oral AZT in syrup was 
given to 100% of the newborns during their first 
hours of life. The importance of elective cesarean 
section is stressed, considering that the possibility 
of using AZT intrapartum was higher among pa-
tients undergoing this procedure. Therefore, it can 
be noted that adequate follow-up with pregnant 
women during prenatal care permits scheduling 
the best mode of delivery according to the recom-
mendations of the Ministério da Saúde (18), de-
creasing the risk of mother-to-child transmission 
0
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Figure 1. Comparative analysis between gestational age and mode of delivery in women 
with HIV/AIDS who received medical care in a public maternity unit of Fortaleza, Ceará, 
Brazil. 2005-2009.
Source: Own elaboration based on data from inpatient and outpatient medical records provided by the health care service for the prevention of 
vertical transmission of the Maternidade Escola Assis Chateaubriand of the Universidade Federal do Ceará.
Note: p-value = <0.001.
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(19), which occurred in the case of the three pa-
tients that were administered monotherapy and 
underwent elective cesarean section.
Out of the eight cases of patients who did not 
receive AZT intrapartum, five were due to lack of 
time for its administration (in two labor was al-
ready at the expulsion stage, in one the labor was 
preterm and in the last there was acute fetal dis-
tress); in two cases it was not prescribed as the 
fetus had died; and in one case there was no data 
on prophylaxis in the medical records.
Although this study uncovered a large number 
of cesarean sections (92.8%) – which present 
higher morbidity compared with vaginal birth (as 
a result of infections, hemorrhages, thrombosis, 
among others) (20) – in Brazil the recommendation 
of the Ministério da Saúde is that if the mother’s 
viral load after week 34 of pregnancy is lower than 
1000 copies/ml, the mode of delivery should be as 
indicated by the obstetrician. However, if the load 
is higher than 1000 copies/ml or is not available, 
elective cesarean section should be prescribed 
(18). The prenatal care service for HIV-positive 
pregnant women does not possess results of viral 
load tests, which compromises the obstetricians’ 
decision-making regarding the most appropriate 
mode of delivery.
It was demonstrated that the professionals 
were able to adopt all recommended measures 
to prevent vertical transmission of HIV, given that 
administration of AZT intrapartum was more fre-
quent among women who underwent cesarean 
section and with less membrane rupture. In the 
results of a meta-analysis, Angelillo and Villari 
(21) observed a significant reduction in the rates 
of perinatal HIV transmission with elective ce-
sarean sections as compared to emergency ce-
sarean deliveries and vaginal births.
Elective cesarean sections should be per-
formed when cervical dilation is less than 4 cen-
timeters and the membrane is intact (between 
weeks 38 and 39 of gestation) so as to prevent 
preterm births. When comparing gestational age at 
birth among the pregnant women who underwent 
elective cesarean section, vaginal birth or cesarean 
section with membrane rupture, a smaller per-
centage of premature babies was observed among 
the first group (11% and 35% respectively).
Some characteristics such as the gestational 
age of the newborn, assessed using the Capurro 
method for birth weight, and the appropriateness 
of weight for gestational age did not show sig-
nificant differences with other results published 
in literature (22). In a multicenter study (23) on 
newborns whose mothers received prophylactic 
zidovudine or other antiretrovirals, 17% of new-
borns were premature, 13% had low birth weight 
and 6% had intrauterine growth retardation; these 
proportions are similar to those of newborns of 
uninfected mothers also receiving adequate pre-
natal care. A study conducted by Lambert et al. 
(24) supports the hypothesis that antiretrovirals, in 
addition to reducing vertical transmission by im-
proving maternal health, can yield better neonatal 
outcomes.
This study illustrates the importance of HIV-
testing during prenatal check-ups, given the 
amount of women who learned their serological 
status through that test. This situation was also de-
scribed in a study conducted in the Netherlands, 
in which 40% of pregnant women learned their 
HIV status at prenatal check-ups (25).
It should be highlighted that the pregnant 
women who had been diagnosed before pregnancy 
had earlier access to the referral services, had more 
prenatal check-ups and began antiretroviral therapy 
earlier, which shows the importance of an early di-
agnosis for a more effective compliance with the 
preventive stages of vertical transmission. Thus, it is 
essential to offer and make available the test prior 
to pregnancy, that is to say, during women’s check-
ups in programs for family planning or gynecologic 
and breast cancer prevention, or at any of their 
visits to the health care centers.
Practically all of the women had a stable 
partner at the time of data collection. The con-
dition of having a partner, which makes women 
wrongly believe that they are safe from the virus, 
in many cases helps increase vulnerability given 
the complexity of using condoms in stable rela-
tionships (26). The possibility of extramarital sex 
by either partner or of infection before the start of 
the relationship should not be dismissed.
Furthermore, not using condoms increases 
the risk of human papillomavirus (HPV) trans-
mission, which is linked to cervical cancer. The 
results of the Papanicolaou tests showed abnor-
malities in 13.1% of samples, which reveals that 
HIV infection is a factor independent from HPV 
infection (27).
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CONCLUSION
This study helps to highlight the importance 
of prenatal care in HIV-positive women. Women’s 
knowledge of diagnosis before pregnancy was 
linked to a higher number of prenatal check-ups 
in the referral service, and allowed for the early 
administration of antiretroviral therapy.
The mode of delivery presented the 
strongest association with administration of AZT 
intrapartum. The highest number of premature 
babies was registered among pregnant women 
with unscheduled deliveries. Perinatal results did 
not show differences with the results found in lit-
erature about HIV-negative mothers.
Finally, it can be concluded that the perfor-
mance of an HIV serologic test during pregnancy 
is an effective measure for good prenatal care. 
Early detection proves beneficial for women and 
their newborns, since HIV transmission can be 
prevented by adopting prophylactic measures.
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